ECM
CTSO icon

Element Capital Management’s Cytosorbents Corp CTSO Stock Holding History

Element Capital Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-30,170
Closed -$213K – 859
2018
Q1 		$213K Buy
+30,170
New +$228K 0.01% 650

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Element Capital Management's CTSO Position: Q2 2018 in Review

Element Capital Management sold out of Cytosorbents Corp (CTSO) in Q2 2018, closing a stake of 30,170 shares — an estimated $213K sold.

Element Capital Management first reported a position in CTSO in Q1 2018 and held it in 1 quarter. The position peaked at $213K in Q1 2018. 75 funds tracked by Wall St. Rank hold CTSO as of Q2 2018.

  • Element Capital Management reported no remaining Cytosorbents Corp position as of Q2 2018 after selling out during the quarter.
  • Element Capital Management sold 30,170 Cytosorbents Corp shares in Q2 2018, an estimated $213K.
  • Element Capital Management first reported a position in Cytosorbents Corp in Q1 2018 and held it in 1 quarter.
  • Element Capital Management's Cytosorbents Corp position peaked at $213K in Q1 2018.
  • 75 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2018.

Based on Element Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.